PLx Pharma Inc. carries a market capitalization of 2.53M, placing it among publicly traded companies globally.
| Market Cap | 2.53M |
| Enterprise Value | N/A |
PLx Pharma Inc.'s stock has declined approximately -95.71429% over the past 52 weeks. The 50-day moving average sits at 0.14, while the 200-day moving average is 0.56.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95.71429% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.56 |
| Average Volume (20 Days) | N/A |
PLx Pharma Inc.'s most recent stock split took place on April 20, 2017 with a 8:1 split ratio.
| Last Split Date | 4/20/2017 |
| Split Ratio | 8:1 |